PRA Health Sciences, Inc. Operating Lease Cost
PRA Health Sciences, Inc. reported Operating Lease Cost of $11.79 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2021-04-29
- PRA Health Sciences, Inc. operating lease, cost for the quarter ending 2021-03-31 was $11.79M, a 5.63% increase year-over-year.
- PRA Health Sciences, Inc. operating lease, cost for the quarter ending 2020-12-31 was $11.25M, a 13.41% decline year-over-year.
- PRA Health Sciences, Inc. operating lease, cost for the quarter ending 2020-09-30 was $11.30M, a 15.50% increase year-over-year.
- PRA Health Sciences, Inc. operating lease, cost for the quarter ending 2020-06-30 was $11.17M, a 19.73% increase year-over-year.
- PRA Health Sciences, Inc. operating lease, cost for fiscal 2020 was $44.89M, a 7.97% increase from fiscal 2019.
- PRA Health Sciences, Inc. operating lease, cost for fiscal 2019 was $41.57M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-03-31 | $11.79M 10-Q · filed 2021-04-29 | $23.04M derived: sum of 2 quarters · filed 2021-04-29 | $34.35M derived: sum of 3 quarters · filed 2021-04-29 | $45.51M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $22.55M derived: sum of 2 quarters · filed 2021-02-24 | $33.72M derived: sum of 3 quarters · filed 2021-02-24 | $44.89M 10-K · filed 2021-02-24 |
| 2020-09-30 | $11.30M 10-Q · filed 2020-11-05 | $22.47M derived: sum of 2 quarters · filed 2020-11-05 | $33.64M 10-Q · filed 2020-11-05 | $46.63M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | $11.17M 10-Q · filed 2020-08-07 | $22.33M 10-Q · filed 2020-08-07 | $35.32M derived: sum of 3 quarters · filed 2021-04-29 | $45.11M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | $11.16M 10-Q · filed 2021-04-29 | $24.15M derived: sum of 2 quarters · filed 2021-04-29 | $33.94M derived: sum of 3 quarters · filed 2021-04-29 | $43.27M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $22.78M derived: sum of 2 quarters · filed 2021-02-24 | $32.10M derived: sum of 3 quarters · filed 2021-02-24 | $41.57M 10-K · filed 2021-02-24 |
| 2019-09-30 | $9.79M 10-Q · filed 2020-11-05 | $19.11M derived: sum of 2 quarters · filed 2020-11-05 | $28.58M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $9.33M 10-Q · filed 2020-08-07 | $18.80M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $9.47M 10-Q · filed 2020-05-01 |